Cargando…
Prevention of Rat Intestinal Injury with a Drug Combination of Melatonin and Misoprostol
A healthy intestinal barrier prevents uptake of allergens and toxins, whereas intestinal permeability increases following chemotherapy and in many gastrointestinal and systemic diseases and disorders. Currently, there are no approved drugs that target and repair the intestinal epithelial barrier whi...
Autores principales: | Dahlgren, David, Cano-Cebrián, Maria-José, Hellström, Per M., Wanders, Alkwin, Sjöblom, Markus, Lennernäs, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555796/ https://www.ncbi.nlm.nih.gov/pubmed/32942716 http://dx.doi.org/10.3390/ijms21186771 |
Ejemplares similares
-
Protective Effects of Melatonin and Misoprostol against Experimentally Induced Increases in Intestinal Permeability in Rats
por: Peters, Karsten, et al.
Publicado: (2022) -
Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies
por: Dahlgren, David, et al.
Publicado: (2021) -
Chemotherapeutics Combined with Luminal Irritants: Effects on Small-Intestinal Mannitol Permeability and Villus Length in Rats
por: Cano-Cebrián, Maria-José, et al.
Publicado: (2022) -
Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat
por: Dahlgren, David, et al.
Publicado: (2020) -
Melatonin-Activated Receptor Signaling Pathways Mediate Protective Effects on Surfactant-Induced Increase in Jejunal Mucosal Permeability in Rats
por: Peters, Karsten, et al.
Publicado: (2021)